Access Statistics for Simona Gamba

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Audit publicity and tax compliance: a quasi-natural experiment 0 0 0 65 0 6 11 146
COVID-19: $R_0$ is lower where outbreak is larger 0 0 0 12 0 3 10 58
COVID-19: R0 is lower where outbreak is larger 0 0 0 29 0 0 9 129
Free-Riding in Pharmaceutical Price Regulation: Theory and Evidence 1 1 3 155 3 10 36 423
Is Tax Compliance a Social Norm? A Field Experiment 0 0 0 251 0 5 18 693
Lies have long legs. Cheating, public scrutiny and loyalty in teams 0 0 1 44 0 6 22 180
My Poor(er) Friend: (Non-)Economic Integration in Public Good Games 0 1 2 24 1 9 27 73
My Poor(er) Friend: (Non-)Economic Integration in Public Good Games 0 1 1 17 0 5 24 53
Optimizing Tax Administration Policies with Machine Learning 0 1 2 267 0 6 29 718
R&D and market size: who benefits from orphan drug regulation? 0 0 0 76 0 4 12 209
Spillovers of Pharmaceutical Price Regulations: evidence from the AMNOG Reform in Germany 2 2 5 28 4 4 27 92
The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector 0 0 0 26 0 6 25 155
The Impact of Social Pressure on Tax Compliance: a Field Experiment 0 0 0 89 1 5 22 150
The Italian Blitz: a natural experiment on audit publicity and tax compliance 0 0 0 67 1 4 13 102
The effect of Intellectual Property Rights on domestic innovation in the pharmaceutical sector 0 0 0 72 1 1 15 135
What exactly is public in a public good game? A lab-in-the-field experiment 1 2 3 159 1 6 19 382
When the two ends meet: an experiment on cooperation across the Italian North-South divide 0 0 0 95 3 6 28 180
Total Working Papers 4 8 17 1,476 15 86 347 3,878


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
An experimental manipulation of divisibility in the public good game 0 1 1 1 0 5 6 6
Audit Publicity and Tax Compliance: A Natural Experiment 0 0 0 17 1 5 12 99
Biomed Europa: After the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly 0 0 0 6 0 4 16 49
COVID-19: R0 is lower where outbreak is larger 0 0 0 3 1 4 16 31
Lies have long legs cheating, peer scrutiny and loyalty in teams 0 0 0 4 0 0 4 26
Machine learning and the optimization of prediction-based policies 0 0 1 6 0 5 26 38
R&D and market size: Who benefits from orphan drug legislation? 0 1 1 5 0 9 19 49
R&D investments, financing constraints, exporting and productivity 0 0 2 59 0 4 20 186
The 2023 European Commission proposal and the 2024 European Parliament proposal for the EU pharmaceutical legislation: policy content analysis 1 1 2 2 2 5 12 12
The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector 0 0 1 20 0 6 18 130
The impact of cost-sharing on prescription drug demand: evidence from a double-difference regression kink design 0 0 0 2 0 1 7 14
The impact of managed entry agreements on pharmaceutical prices 0 0 1 16 0 5 20 98
The impact of social pressure on tax compliance: A field experiment 0 0 2 28 0 5 12 139
When the two ends meet: an experiment on cooperation and social capital 0 1 2 7 1 6 24 51
Total Journal Articles 1 4 13 176 5 64 212 928


Statistics updated 2026-06-04